UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005614
Receipt number R000006633
Scientific Title Expression of CTLA4 on peripheral mononuclear cells of patients with rheumatoid arthritis
Date of disclosure of the study information 2011/05/17
Last modified on 2013/09/03 17:25:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Expression of CTLA4 on peripheral mononuclear cells of patients with rheumatoid arthritis

Acronym

CTLA4 expression in RA

Scientific Title

Expression of CTLA4 on peripheral mononuclear cells of patients with rheumatoid arthritis

Scientific Title:Acronym

CTLA4 expression in RA

Region

Japan


Condition

Condition

Rheumatoid arthritis

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the expression of CTLA4 after stimulation by anti-CD3 and anti-CD28

Basic objectives2

Others

Basic objectives -Others

To evaluate the function of peripheral blood mononuclear cells (PBMCs)

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

CTLA4 expression on PBMC

Key secondary outcomes

None


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Drawing peripheral blood

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

People who had informed consent to this study

Key exclusion criteria

People who did not have informed consent to this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichi Amano

Organization

Saitama Medical Center,
Saitama Medical University

Division name

Department of Rheumatology and Clinical Immunology

Zip code


Address

1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan

TEL

049-228-3859

Email

amanokoi@saitama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koichi Amano

Organization

Saitama Medical Center, Saitama Medical University Saitama Medical Center, Saitama Medical Univers

Division name

Department of Rheumatology and Clinical Immunology

Zip code


Address

1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan

TEL

049-228-3859

Homepage URL


Email

amanokoi@saitama-med.ac.jp


Sponsor or person

Institute

Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 06 Month 01 Day

Last follow-up date

2013 Year 12 Month 01 Day

Date of closure to data entry

2013 Year 12 Month 01 Day

Date trial data considered complete

2014 Year 03 Month 01 Day

Date analysis concluded

2014 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 05 Month 17 Day

Last modified on

2013 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006633


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name